FI973185A0 - Use of melatonin in the treatment of patients with drug dependence - Google Patents

Use of melatonin in the treatment of patients with drug dependence

Info

Publication number
FI973185A0
FI973185A0 FI973185A FI973185A FI973185A0 FI 973185 A0 FI973185 A0 FI 973185A0 FI 973185 A FI973185 A FI 973185A FI 973185 A FI973185 A FI 973185A FI 973185 A0 FI973185 A0 FI 973185A0
Authority
FI
Finland
Prior art keywords
melatonin
patients
treatment
drug dependence
dependence
Prior art date
Application number
FI973185A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI973185A (en
FI119586B (en
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of FI973185A0 publication Critical patent/FI973185A0/en
Publication of FI973185A publication Critical patent/FI973185A/en
Application granted granted Critical
Publication of FI119586B publication Critical patent/FI119586B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI973185A 1995-02-01 1997-07-31 Use of melatonin for the manufacture of a drug for the treatment of patients suffering from drug dependence FI119586B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US38153595 1995-02-01
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853 1995-06-06
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
IB9600082 1996-01-29
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (3)

Publication Number Publication Date
FI973185A0 true FI973185A0 (en) 1997-07-31
FI973185A FI973185A (en) 1997-09-30
FI119586B FI119586B (en) 2009-01-15

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973185A FI119586B (en) 1995-02-01 1997-07-31 Use of melatonin for the manufacture of a drug for the treatment of patients suffering from drug dependence

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2396129C (en) 2000-01-05 2010-11-30 Neurim Pharmaceuticals (1991) Ltd. Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
SI2806863T1 (en) 2012-01-26 2017-12-29 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
CN110200958A (en) 2012-12-18 2019-09-06 万达制药公司 The treatment of circadian rhythm disorder
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
AU2016426598C1 (en) * 2016-10-31 2024-02-08 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518468B1 (en) * 1991-05-09 1999-06-30 Neurim Pharmaceuticals (1991) Limited Melatonin containing compositions
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
DK89697A (en) 1997-07-30
AU695366B2 (en) 1998-08-13
FI973185A (en) 1997-09-30
FI119586B (en) 2009-01-15
MD1716B2 (en) 2001-08-31
EE03384B1 (en) 2001-04-16
LV11940A (en) 1998-01-20
AT408188B (en) 2001-09-25
NO973531D0 (en) 1997-07-31
CZ291349B6 (en) 2003-02-12
SK103097A3 (en) 1998-01-14
AU4457496A (en) 1996-08-21
MX9705856A (en) 1998-07-31
BG62876B1 (en) 2000-10-31
BR9607169A (en) 1997-11-11
SI9620022A (en) 1998-10-31
EE9700166A (en) 1998-02-16
MD970254A (en) 1999-05-31
LU90118B1 (en) 1997-11-13
CN1172431A (en) 1998-02-04
NZ298878A (en) 1999-05-28
JP4516159B2 (en) 2010-08-04
DK176081B1 (en) 2006-04-18
MD1716C2 (en) 2002-02-28
SK284521B6 (en) 2005-05-05
WO1996023496A1 (en) 1996-08-08
IS4532A (en) 1997-07-25
JPH10513177A (en) 1998-12-15
CN1083263C (en) 2002-04-24
NO312814B1 (en) 2002-07-08
IS1980B (en) 2005-01-14
TW483757B (en) 2002-04-21
ATA901396A (en) 2001-02-15
PL183148B1 (en) 2002-05-31
NO973531L (en) 1997-09-30
LV11940B (en) 1998-05-20
CZ240597A3 (en) 1998-01-14
TR199700723T1 (en) 1998-02-21
BG101803A (en) 1998-04-30
PL321630A1 (en) 1997-12-08

Similar Documents

Publication Publication Date Title
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
LV11615A (en) Amid with medical treatment
EE03512B1 (en) Epinastine for use in the treatment of pain
LV10878A (en) Treatment of the skin with selected amphiphilic copolymers
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
DE69310325T2 (en) Patient treatment device with mattress and treatment chamber
DK0668763T3 (en) Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders
NO975718D0 (en) Treatment of insulin resistance
FI973185A (en) Use of melatonin in the treatment of patients with drug dependence
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
FI941345A0 (en) Retinoids and their use in the treatment of skin diseases and leukemia
KR960702315A (en) Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage
ATA18093A (en) HYPERTHERMAL TREATMENT CATHETER
DE59811703D1 (en) Medical or dental treatment chair
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
DE29702277U1 (en) Medical diagnostic and / or therapy device
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
DE29702126U1 (en) Therapy and treatment cabin
ITFI920241A0 (en) USE OF MELATONIN IN THE THERAPY OF SYSTEMATIC SCLEROSIS, SARCOIDOSIS AND OTHERS
DE29713580U1 (en) Medical or dental treatment chair
YU40098A (en) The use of olanzapine in preparation of medicine
KR950008161U (en) Personal poultice sauna
KR980000770U (en) Medical treatment device with desk
KR950003086U (en) Infrared Therapy for Medical Science

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119586

Country of ref document: FI

MA Patent expired